Literature DB >> 24022303

Parental mosaicism is a pitfall in preimplantation genetic diagnosis of dominant disorders.

Julie Steffann1, Caroline Michot1, Roxana Borghese1, Marcia Baptista-Fernandes1, Sophie Monnot1, Jean-Paul Bonnefont1, Arnold Munnich1.   

Abstract

PCR amplification on single cells is prone to allele drop-out (PCR failure of one allele), a cause of misdiagnosis in preimplantation genetic diagnosis (PGD). Owing to this error risk, PGD usually relies on both direct and indirect genetic analyses. When the affected partner is the sporadic case of a dominant disorder, building haplotypes require spermatozoon or polar body testing prior to PGD, but these procedures are cost and time-consuming. A couple requested PGD because the male partner suffered from a dominant Cowden syndrome (CS). He was a sporadic case, but the couple had a first unaffected child and the non-mutated paternal haplotype was tentatively deduced. The couple had a second spontaneous pregnancy and the fetus was found to carry the at-risk haplotype but not the PTEN mutation. The mutation was present in blood from the affected father, but at low level, confirming the somatic mosaicism. Ignoring the possibility of mosaicism in the CS patient would have potentially led to selection of affected embryos. This observation emphasizes the risk of PGD in families at risk to transmit autosomal-dominant disorder when the affected partner is a sporadic case.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24022303      PMCID: PMC3992558          DOI: 10.1038/ejhg.2013.164

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  6 in total

1.  ESHRE PGD consortium best practice guidelines for amplification-based PGD.

Authors:  G L Harton; M De Rycke; F Fiorentino; C Moutou; S SenGupta; J Traeger-Synodinos; J C Harper
Journal:  Hum Reprod       Date:  2010-10-21       Impact factor: 6.918

2.  Severe Lhermitte-Duclos disease with unique germline mutation of PTEN.

Authors:  R Sutphen; T M Diamond; S E Minton; M Peacocke; H C Tsou; A W Root
Journal:  Am J Med Genet       Date:  1999-02-12

Review 3.  Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?

Authors:  H Kehrer-Sawatzki; D N Cooper
Journal:  J Med Genet       Date:  2008-05-29       Impact factor: 6.318

4.  Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex.

Authors:  Wei Qin; Piotr Kozlowski; Bruce E Taillon; Pascal Bouffard; Alison J Holmes; Pasi Janne; Susana Camposano; Elizabeth Thiele; David Franz; David J Kwiatkowski
Journal:  Hum Genet       Date:  2010-02-18       Impact factor: 4.132

5.  Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome.

Authors:  Jessica Mester; Charis Eng
Journal:  Genet Med       Date:  2012-05-17       Impact factor: 8.822

6.  Recurrence of perinatal lethal osteogenesis imperfecta in sibships: parsing the risk between parental mosaicism for dominant mutations and autosomal recessive inheritance.

Authors:  Shawna M Pyott; Melanie G Pepin; Ulrike Schwarze; Kathleen Yang; Gretchen Smith; Peter H Byers
Journal:  Genet Med       Date:  2011-02       Impact factor: 8.822

  6 in total
  1 in total

1.  Next-generation sequence-based preimplantation genetic testing for monogenic disease resulting from maternal mosaicism.

Authors:  Xiao Hu; Wen-Bin He; Shuo-Ping Zhang; Ke-Li Luo; Fei Gong; Jing Dai; Yi Zhang; Zhen-Xing Wan; Wen Li; Shi-Min Yuan; Yue-Qiu Tan; Guang-Xiu Lu; Ge Lin; Juan Du
Journal:  Mol Genet Genomic Med       Date:  2021-05-04       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.